Freedom251 › AI Drug Discovery Software
BioNeMo
by NVIDIA
Plans
| Plan | Billed and limits | Price |
|---|---|---|
| BioNeMo Framework Community Resource | Free community resource · GPU-based computational resources | Free |
As nvidia.com lists them, read 14 Nov 2026. The maker's own page has the final word.
Facts from NVIDIA's own pages
- Access
- Pretrained models can be accessed through cloud APIs or a web interface for interactive inference, visualization, and experimentation. · nvidia.com, 14 Nov 2026
- Documentation status
- BioNeMo Framework documentation is being refactored as NVIDIA consolidates parallelism-training code with BioNeMo Recipes. · docs.nvidia.com, 14 Nov 2026
- Drug discovery applications
- The product supports model customization and deployment for protein structure prediction, molecule generation, property prediction, and molecular docking. · nvidia.com, 14 Nov 2026
- Early access
- The BioNeMo product page directs visitors to apply for early access. · nvidia.com, 14 Nov 2026
- Enterprise support
- NVIDIA says an enterprise license is available for improved expert-level support. · docs.nvidia.com, 14 Nov 2026
- Framework scope
- BioNeMo Framework is a collection of programming tools, libraries, and models for computational drug discovery. · docs.nvidia.com, 14 Nov 2026
- GPU requirement
- BioNeMo Recipes require an environment with access to NVIDIA GPUs; bfloat16 requires Ampere-generation GPUs or newer. · docs.nvidia.com, 14 Nov 2026
- Intended audience
- NVIDIA presents BioNeMo as a tool for researchers and developers working on AI-powered drug discovery. · nvidia.com, 14 Nov 2026
- Models
- The documentation lists Amplify, Evo2, Geneformer, and ESM 2 among the framework models. · docs.nvidia.com, 14 Nov 2026
- Performance and integration
- The framework provides optimized models and tooling designed to integrate with GPU-based computational resources. · docs.nvidia.com, 14 Nov 2026
- Purpose
- BioNeMo is a generative AI platform for drug discovery that supports training models on users’ own data and scalable model deployment. · nvidia.com, 14 Nov 2026
- Training infrastructure
- NVIDIA describes training and optimization using DGX Cloud, its multi-node AI training-as-a-service solution. · nvidia.com, 14 Nov 2026
- Unsupported GPU use
- Running BioNeMo without bfloat16 may be possible, but the development team does not support that use case. · docs.nvidia.com, 14 Nov 2026
Where BioNeMo stands on Freedom251
- AI Drug Discovery Software#1 of 33